Siemens ADVIA Centaur¿ Calibrator U, For in vitro diagnostic use in calibrating the following as...

FDA Device Recall #Z-2899-2016 — Class II — August 8, 2016

Recall Summary

Recall Number Z-2899-2016
Classification Class II — Moderate risk
Date Initiated August 8, 2016
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Siemens Healthcare Diagnostics, Inc
Location East Walpole, MA
Product Type Devices
Quantity 2,248 kits

Product Description

Siemens ADVIA Centaur¿ Calibrator U, For in vitro diagnostic use in calibrating the following assays using ADVIA Centaur"' systems: Myoglobin cTnl Cat No. ADVIA Centaur Calibrator U (2 Pack) - 03684480 (SMN 1 0309996)

Reason for Recall

Failure of analytical sensitivity with Calibrator U kit lots ending in 63 and 64 and a drift from the internal standardization

Distribution Pattern

Worldwide Distribution - Nationwide Distribution including the countries of: Argentina Australia Brazil Canada Chile China Ecuador India Japan Korea Mexico Malaysia Peru Philippines Saudi Arabia Singapore Taiwan Vietnam South Africa

Lot / Code Information

Kit Lots ending in 63 and 64 as follows: 65710A63, 77825A63, 99481A64, 08835A64, 22955A64

Other Recalls from Siemens Healthcare Diagnostics, Inc

Recall # Classification Product Date
Z-0124-2022 Class II Atellica IM 1300 Analyzer, SMN 11066001 Sep 28, 2021
Z-0125-2022 Class II Atellica IM 1600 Analyzer, SMN 11066000 Sep 28, 2021
Z-0196-2022 Class II ADVIA Centaur SARS-CoV-2 Antigen Assay (100 Tes... Sep 22, 2021
Z-0195-2022 Class II Atellica IM SARS-CoV-2 Antigen Assay (100 Test ... Sep 22, 2021
Z-2425-2021 Class II Atellica IM BR 27.29 (BR) Assay 250 Test Kit- i... Jul 6, 2021

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.